4YND
The Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2
Summary for 4YND
| Entry DOI | 10.2210/pdb4ynd/pdb |
| Descriptor | N-lysine methyltransferase SMYD2, ZINC ION, N-cyclohexyl-N~3~-[2-(3,4-dichlorophenyl)ethyl]-N-(2-{[(2R)-2-hydroxy-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-8-yl)ethyl]amino}ethyl)-beta-alaninamide, ... (5 entities in total) |
| Functional Keywords | epigenetics, smyd2, h3k36, p53, methyltransferase, lysine, transferase-inhibitor complex, transferase/inhibitor |
| Biological source | Homo sapiens (Human) |
| Cellular location | Cytoplasm, cytosol : Q9NRG4 |
| Total number of polymer chains | 1 |
| Total formula weight | 54378.00 |
| Authors | Sweis, R.F.,Wang, Z.,Algire, M.,Arrowsmith, C.H.,Brown, P.J.,Chiang, G.C.,Guo, J.,Jakob, C.G.,Kennedy, S.,Li, F.,Soni, N.B.,Vedadi, M.,Pappano, W.N. (deposition date: 2015-03-09, release date: 2015-05-20, Last modification date: 2023-09-27) |
| Primary citation | Sweis, R.F.,Wang, Z.,Algire, M.,Arrowsmith, C.H.,Brown, P.J.,Chiang, G.G.,Guo, J.,Jakob, C.G.,Kennedy, S.,Li, F.,Maag, D.,Shaw, B.,Soni, N.B.,Vedadi, M.,Pappano, W.N. Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2. Acs Med.Chem.Lett., 6:695-700, 2015 Cited by PubMed Abstract: A lack of useful small molecule tools has precluded thorough interrogation of the biological function of SMYD2, a lysine methyltransferase with known tumor-suppressor substrates. Systematic exploration of the structure-activity relationships of a previously known benzoxazinone compound led to the synthesis of A-893, a potent and selective SMYD2 inhibitor (IC50: 2.8 nM). A cocrystal structure reveals the origin of enhanced potency, and effective suppression of p53K370 methylation is observed in a lung carcinoma (A549) cell line. PubMed: 26101576DOI: 10.1021/acsmedchemlett.5b00124 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.79 Å) |
Structure validation
Download full validation report






